Muscle-building supplements may be associated with testicular cancer
the ONA take:
According to a new study published in the British Journal of Cancer, researchers have found that men who reported taking muscle-building supplements, such as powders and pills with androstenedione or creatine, had a significantly increased likelihood of developing testicular cancer compared with men who did not use those supplements.
For the study, researchers surveyed about 900 men from Connecticut and Massachusetts. Of those, 356 had been diagnosed with testicular germ cell cancer while 513 had not been diagnosed with testicular cancer.
Participants were were asked about exercise, drinking, and smoking habits, family history of testicular cancer, supplement use, and prior injury to their groin or testicles.
Results showed that men who had used supplements had a 65% higher risk of developing testicular cancer than those who did not.
Those who used more than one kind of supplement had a 177% higher risk than those that did not use supplements, and participants that used supplements for at least 3 years had a 156% higher risk.
Researchers also found that men who started using supplements at or before age 25 had a 121% higher risk of developing testicular cancer.
Taking muscle-building supplements significantly increases likelihood of developing testicular cancer.
- Prehabilitation Program Improves Preoperative Fitness in Patients With Colorectal Cancer
- Acupuncture Improves Postoperative Symptoms in Women Undergoing Surgery for Breast Cancer
- Combination of Gemcitabine and New CHK1 Inhibitor Is Effective in Soft Tissue Sarcomas
- Alcohol Consumption, Particularly White Wine, Associated With Increased Risk of Melanoma
- In HER2+ Breast Cancer, Higher TIL Levels Associated With Improved OS
- Exercise is as Effective in Treating Metastatic Prostate Cancer as Medication
- Walnut Consumption Changes Gut Microbiome, Decreases Growth of Colon Cancer in Mice
- Vaccine Enters Phase I Study for Safety and Effectiveness in Multiple Myeloma
- Timing Chemotherapy Administration to Circadian Rhythm Improves Drug Effectiveness
- New Therapy Blocks Breast Cancer Cells From Entering and Hiding in Bone Marrow to Form Latent Metastases
- Netupitant/Palonosetron Efficacious for Prevention of N/V in Patients Receiving MEC or HEC
- Costs, Complications Higher for Women Who Undergo Second Surgery After BCS
- Omitting RT in Certain Older Women With Early Breast Cancer is Safe
- Fluorescent Nanoparticles Represent Novel Detection Method of HER2 Expression
- Assessment of Stromal Features in DCIS Requires Robustness
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|